COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASES

The purpose of the study was to improve treatment outcomes for patients with inoperable colorectal liver metastases using the  combination of chemoembilization of the hepatic artery and radiofrequency ablation.Material and methods. Treatment outcomes of 60 patients with methachronic unresectable liv...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Shabunin, M. M. Tavobilov, D. N. Grekov, P. A. Drozdov
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2018-07-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/761
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699961324699648
author A. V. Shabunin
M. M. Tavobilov
D. N. Grekov
P. A. Drozdov
author_facet A. V. Shabunin
M. M. Tavobilov
D. N. Grekov
P. A. Drozdov
author_sort A. V. Shabunin
collection DOAJ
description The purpose of the study was to improve treatment outcomes for patients with inoperable colorectal liver metastases using the  combination of chemoembilization of the hepatic artery and radiofrequency ablation.Material and methods. Treatment outcomes of 60 patients with methachronic unresectable liver metastases from colorectal cancer  were analyzed. Eligibility criteria were as follows: absence of  extrahepatic metastases, size of metastases from 3 to 5 cm, and  inability to perform resection. All patients were divided into two groups. Group I included 30 patients who received combination  of regional chemotherapy and radiofrequency ablation. Group II (the control group) consisted of 30 patients who received radiofrequency ablation only.Results. Post-embolization and post-ablation syndromes were observed in both groups of patients. Rightsided hydrothorax  (Clavien-Dindo grade II) was found in 4 out of 60 patients (2  patients in Group I and 2 patients in Group II). One-, two- and  three-year disease-free survival rates in Group I patients were 96.6  %, 76.6 % and 53.3 %, respectively. The corresponding rates in the  control group patients were 90.0 %, 53.6 % and 30.0 %,  respectively (p=0.049). The overall one-, two-and three-year  survival rates in Group I patients were 100 %, 90 % and 63.3 %,  respectively. The corresponding rates in the control group patients  were 100 %, 70 % and 50.0 %, respectively (p=0.202).Conclusion. The combination of regional chemotherapy and radiofrequency ablation led to the improvement in overall and disease-free survival rates.
format Article
id doaj-art-1efc8a491c0844f2865737cb3c957df7
institution DOAJ
issn 1814-4861
2312-3168
language Russian
publishDate 2018-07-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj-art-1efc8a491c0844f2865737cb3c957df72025-08-20T03:18:26ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682018-07-01173344010.21294/1814-4861-2018-17-3-34-40543COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASESA. V. Shabunin0M. M. Tavobilov1D. N. Grekov2P. A. Drozdov3Russian Medical Academy of Postgraduate Education S.P. Botkin City Clinical HospitalRussian Medical Academy of Postgraduate Education S.P. Botkin City Clinical HospitalRussian Medical Academy of Postgraduate Education S.P. Botkin City Clinical HospitalS.P. Botkin City Clinical HospitalThe purpose of the study was to improve treatment outcomes for patients with inoperable colorectal liver metastases using the  combination of chemoembilization of the hepatic artery and radiofrequency ablation.Material and methods. Treatment outcomes of 60 patients with methachronic unresectable liver metastases from colorectal cancer  were analyzed. Eligibility criteria were as follows: absence of  extrahepatic metastases, size of metastases from 3 to 5 cm, and  inability to perform resection. All patients were divided into two groups. Group I included 30 patients who received combination  of regional chemotherapy and radiofrequency ablation. Group II (the control group) consisted of 30 patients who received radiofrequency ablation only.Results. Post-embolization and post-ablation syndromes were observed in both groups of patients. Rightsided hydrothorax  (Clavien-Dindo grade II) was found in 4 out of 60 patients (2  patients in Group I and 2 patients in Group II). One-, two- and  three-year disease-free survival rates in Group I patients were 96.6  %, 76.6 % and 53.3 %, respectively. The corresponding rates in the  control group patients were 90.0 %, 53.6 % and 30.0 %,  respectively (p=0.049). The overall one-, two-and three-year  survival rates in Group I patients were 100 %, 90 % and 63.3 %,  respectively. The corresponding rates in the control group patients  were 100 %, 70 % and 50.0 %, respectively (p=0.202).Conclusion. The combination of regional chemotherapy and radiofrequency ablation led to the improvement in overall and disease-free survival rates.https://www.siboncoj.ru/jour/article/view/761liver metastasescolorectal cancerchemoembolization of the hepatic arteryradiofrequency ablationcombined modality treatment
spellingShingle A. V. Shabunin
M. M. Tavobilov
D. N. Grekov
P. A. Drozdov
COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASES
Сибирский онкологический журнал
liver metastases
colorectal cancer
chemoembolization of the hepatic artery
radiofrequency ablation
combined modality treatment
title COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASES
title_full COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASES
title_fullStr COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASES
title_full_unstemmed COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASES
title_short COMBINED MODALITY TREATMENT FOR PATIENTS WITH INOPERABLE COLORECRAL LIVER METASTASES
title_sort combined modality treatment for patients with inoperable colorecral liver metastases
topic liver metastases
colorectal cancer
chemoembolization of the hepatic artery
radiofrequency ablation
combined modality treatment
url https://www.siboncoj.ru/jour/article/view/761
work_keys_str_mv AT avshabunin combinedmodalitytreatmentforpatientswithinoperablecolorecrallivermetastases
AT mmtavobilov combinedmodalitytreatmentforpatientswithinoperablecolorecrallivermetastases
AT dngrekov combinedmodalitytreatmentforpatientswithinoperablecolorecrallivermetastases
AT padrozdov combinedmodalitytreatmentforpatientswithinoperablecolorecrallivermetastases